BEIJING, March 9, 2011 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company"), a leading China-based biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hospital-based medical products, today announced that the Company plans to release fourth quarter and full year 2010 financial results on Wednesday, March 16, 2011, after market close.
The Company will hold a conference call at 8:00 am ET on Thursday, March 17, 2011 to discuss fourth quarter and full year 2010 results. Listeners may access the call by dialing:
A telephone replay will be available beginning two hours after the conclusion of the call and will be available through March 31, 2011. Listeners may access the replay by dialing:
A webcast will also be available through the Company's website www.nkbp.com.
About China Nuokang Bio-Pharmaceutical Inc.
China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) is a leading biopharmaceutical company in China focused on the research, development, manufacture, marketing and sales of hospital-based medical products. The Company provides a diversified portfolio of products across more than 2,400 hospitals in China. Nuokang's principal products include Baquting®, China's leading hemocoagulase product by market share, and Aiduo®, a cardiovascular stress imaging agent. The Company's product pipeline includes product candidates under development in hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention. Please visit www.nkbp.com for more information.
CONTACT: ICR, LLC In the U.S.: Ashley M. Ammon and Christine Duan: 1-646-277-1227 In China: Wen Lei Zheng: 86-10-6583-7510